FindTrial
Sign In

Pathophysiological mechanisms of hypertensive left ventricular hypertrophy: optimising regression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN79725810
Enrollment
Unknown
Registered
2003-09-12
Start date
2002-08-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular: Hypertensive left ventricular hypertrophy (LVH) Circulatory System Hypertensive left ventricular hypertrophy (LVH)

Interventions

Laboratory study
Randomised controlled trial, Random allocation to different combinations of standard blood pressure treatments. Random allocation to: A. Treatment one B. Treatment two C. Treatment three D. Treatm

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All recruited patients will have hypertension and left ventricular hypertrophy.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Magnetic resonance imaging (MRI) measurement of left ventricular mass regression.—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026